BDBM145392 US8952169, 171::US8952169, 267

SMILES: CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2(CC2)C(F)(F)F)cc1F

InChI Key: InChIKey=FKAFQFFYKBCSIF-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 145392   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human))	BDBM145392 (US8952169, 171 | US8952169, 267) Show SMILES CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2(CC2)C(F)(F)F)cc1F Show InChI InChI=1S/C16H17F4NO4S/c1-26(23,24)21-14(22)11-6-10(9-2-3-9)13(7-12(11)17)25-8-15(4-5-15)16(18,19)20/h6-7,9H,2-5,8H2,1H3,(H,21,22)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	25
Xenon Pharmaceuticals Inc.; Genentech, Inc. US Patent					Assay Description Radioligand Binding Studies: Saturation experiments. A representative compound of formula (I) was tritiated. Three tritiums were incorporated in plac...				US Patent US8952169 (2015) BindingDB Entry DOI: 10.7270/Q2M04445
					More data for this Ligand-Target Pair
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human))	BDBM145392 (US8952169, 171 | US8952169, 267) Show SMILES CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2(CC2)C(F)(F)F)cc1F Show InChI InChI=1S/C16H17F4NO4S/c1-26(23,24)21-14(22)11-6-10(9-2-3-9)13(7-12(11)17)25-8-15(4-5-15)16(18,19)20/h6-7,9H,2-5,8H2,1H3,(H,21,22)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	25
Xenon Pharmaceuticals Inc.; Genentech, Inc. US Patent					Assay Description Radioligand Binding Studies: Saturation experiments. A representative compound of formula (I) was tritiated. Three tritiums were incorporated in plac...				US Patent US8952169 (2015) BindingDB Entry DOI: 10.7270/Q2M04445
					More data for this Ligand-Target Pair
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human))	BDBM145392 (US8952169, 171 | US8952169, 267) Show SMILES CS(=O)(=O)NC(=O)c1cc(C2CC2)c(OCC2(CC2)C(F)(F)F)cc1F Show InChI InChI=1S/C16H17F4NO4S/c1-26(23,24)21-14(22)11-6-10(9-2-3-9)13(7-12(11)17)25-8-15(4-5-15)16(18,19)20/h6-7,9H,2-5,8H2,1H3,(H,21,22)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	60	n/a	n/a	n/a	n/a	7.4	25
Xenon Pharmaceuticals Inc.; Genentech, Inc. US Patent					Assay Description Radioligand Binding Studies: Saturation experiments. A representative compound of formula (I) was tritiated. Three tritiums were incorporated in plac...				US Patent US8952169 (2015) BindingDB Entry DOI: 10.7270/Q2M04445
					More data for this Ligand-Target Pair